Metabolic Risk Factors and Ursodiol Response in Primary Biliary Cholangitis

被引：0
|
作者：
Zouridis, Spyridon [1 ]
Nguyen, Khang [2 ]
Lee, Felicia [2 ]
Qureshi, Kamran [2 ]
机构：
[1] SSM Hlth St Louis Univ Hosp, St Louis, MO USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036884.76550.3a
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1879
引用
收藏
页码：S1350 / S1351
页数：2
相关论文
共 50 条
  • [21] Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
    Sarcognato, Samantha
    Sacchi, Diana
    Grillo, Federica
    Cazzagon, Nora
    Fabris, Luca
    Cadamuro, Massimiliano
    Cataldo, Ivana
    Covelli, Claudia
    Mangia, Alessandra
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 170 - 184
  • [22] Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
    Martinez-Gili, Laura
    Pechlivanis, Alexandros
    McDonald, Julie A. K.
    Begum, Sofina
    Badrock, Jonathan
    Dyson, Jessica K.
    Jones, Rebecca
    Hirschfield, Gideon
    Ryder, Stephen D.
    Sandford, Richard
    Rushbrook, Simon
    Thorburn, Douglas
    Taylor-Robinson, Simon D.
    Crossey, Mary M. E.
    Marchesi, Julian R.
    Mells, George
    Holmes, Elaine
    Jones, David
    GUT MICROBES, 2023, 15 (01)
  • [23] Primary biliary Cholangitis - Bezafibrate improves biochemical Response
    Brudermanns, Britta
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (16)
  • [24] Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouilleres
    Efe, Cumali
    Tascilar, Koray
    Montano-Loza, Aldo J.
    Yoshida, Eric M.
    Wahlin, Staffan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (10): : 1692 - 1692
  • [25] Risk stratification and prognostic modelling in primary biliary cholangitis
    Goet, Jorn C.
    Harms, Maren H.
    Carbone, Marco
    Hansen, Bettina E.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2018, 34-35 : 95 - 106
  • [26] Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol
    Ghonem, Nisanne S.
    Auclair, Adam M.
    Hemme, Christopher L.
    Gallucci, Gina M.
    de la Rosa Rodriguez, Randolph
    Boyer, James L.
    Assis, David N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1213 - 1223
  • [27] Primary Biliary Cholangitis
    Andrew R. Scheinberg
    Cynthia Levy
    Current Treatment Options in Gastroenterology, 2022, 20 (3) : 469 - 483
  • [28] Primary Biliary Cholangitis
    Suraweera, Duminda
    Reynolds, Courtney
    Thangaratnam, Shehan
    Singhvi, Gaurav
    PRACTICAL GASTROENTEROLOGY, 2016, 40 (01) : 48 - 59
  • [29] Primary biliary cholangitis
    Lleo, Ana
    Wang, Giu-Qiang
    Gershwin, Merrill Eric
    Hirschfield, Gideon M.
    LANCET, 2020, 396 (10266): : 1915 - 1926
  • [30] Primary biliary cholangitis
    Tanakai, Atsushi
    Mai, Xiong
    Takahashi, Atsushi
    Vierling, John M.
    LANCET, 2024, 404 (10457): : 1053 - 1066
12345